S&P 500   2,999.20 (+0.11%)
DOW   26,806.87 (+0.07%)
QQQ   191.80 (-0.03%)
AAPL   242.45 (+1.04%)
FB   184.71 (+1.30%)
MSFT   135.91 (-0.34%)
GOOGL   1,250.40 (+0.74%)
AMZN   1,754.42 (-0.64%)
CGC   21.35 (+0.95%)
NVDA   195.18 (-0.22%)
MU   44.62 (-0.09%)
BABA   169.32 (-0.34%)
GE   9.12 (+0.55%)
TSLA   254.65 (-0.36%)
AMD   31.56 (+0.16%)
T   37.85 (-0.86%)
NFLX   272.60 (+2.22%)
BAC   31.30 (+0.32%)
GILD   66.30 (+0.67%)
DIS   131.03 (-1.04%)
S&P 500   2,999.20 (+0.11%)
DOW   26,806.87 (+0.07%)
QQQ   191.80 (-0.03%)
AAPL   242.45 (+1.04%)
FB   184.71 (+1.30%)
MSFT   135.91 (-0.34%)
GOOGL   1,250.40 (+0.74%)
AMZN   1,754.42 (-0.64%)
CGC   21.35 (+0.95%)
NVDA   195.18 (-0.22%)
MU   44.62 (-0.09%)
BABA   169.32 (-0.34%)
GE   9.12 (+0.55%)
TSLA   254.65 (-0.36%)
AMD   31.56 (+0.16%)
T   37.85 (-0.86%)
NFLX   272.60 (+2.22%)
BAC   31.30 (+0.32%)
GILD   66.30 (+0.67%)
DIS   131.03 (-1.04%)
Log in

iShares US Pharmaceuticals ETF Stock Price, News & Analysis (NYSEARCA:IHE)

$140.57
-0.26 (-0.18 %)
(As of 10/23/2019 12:21 PM ET)
Add
Today's Range
$140.57
Now: $140.57
$140.57
50-Day Range
$137.13
MA: $141.24
$144.49
52-Week Range
$131.91
Now: $140.57
$161.06
Volume35 shs
Average Volume14,826 shs
Market Capitalization$323.31 million
P/E RatioN/A
Dividend Yield1.46%
BetaN/A
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors.

Basic Details

Issuer iShares
Fund NameiShares US Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IHE
Inception Date5/1/2006
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkDow Jones US Select Pharmaceuticals Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$325.72 million
Average Daily Volume$38,498.10
Discount/Premium0.07%

ETF Expenses

Management Fee0.44%
Other Expenses0.00%
Total Expenses0.44%
Fee Waiver0.00%
Net Expenses0.44%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerIMC Chicago

Receive IHE News and Ratings via Email

Sign-up to receive the latest news and ratings for IHE and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Currency Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Sector Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Industry Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

iShares US Pharmaceuticals ETF (NYSEARCA:IHE) Frequently Asked Questions

What is iShares US Pharmaceuticals ETF's stock symbol?

iShares US Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IHE."

How often does iShares US Pharmaceuticals ETF pay dividends? What is the dividend yield for iShares US Pharmaceuticals ETF?

iShares US Pharmaceuticals ETF declared a -- dividend on Tuesday, September 24th. Shareholders of record on Wednesday, September 25th will be given a dividend of $0.6295 per share on Monday, September 30th. This represents a yield of 1.3%. The ex-dividend date is Tuesday, September 24th. View iShares US Pharmaceuticals ETF's Dividend History.

Has iShares US Pharmaceuticals ETF been receiving favorable news coverage?

News stories about IHE stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares US Pharmaceuticals ETF earned a news sentiment score of 0.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for iShares US Pharmaceuticals ETF.

What other stocks do shareholders of iShares US Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares US Pharmaceuticals ETF investors own include Adobe (ADBE), Broadcom (AVGO), Baidu (BIDU), Biogen (BIIB), Brooks Automation (BRKS), Caesars Entertainment (CZR), Mylan (MYL), PepsiCo (PEP), Starbucks (SBUX) and Skyworks Solutions (SWKS).

Who are iShares US Pharmaceuticals ETF's key executives?

iShares US Pharmaceuticals ETF's management team includes the folowing people:
  • George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees (Age 78)
  • Michael Arthur Latham, President, Trustee (Age 51)
  • Jack Gee, Chief Financial Officer, Treasurer (Age 57)
  • Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
  • Amy Schioldager, Executive Vice President (Age 56)
  • Ira P. Shapiro, Vice President, Chief Legal Officer (Age 52)
  • Matt Tucker, Vice President
  • Eilleen M. Clavere, Secretary (Age 61)
  • Cecilia H. Herbert, Independent Trustee (Age 68)
  • Charles A. Hurty, Independent Trustee (Age 73)

Who are iShares US Pharmaceuticals ETF's major shareholders?

iShares US Pharmaceuticals ETF's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Murphy Capital Management Inc. (1.04%), Envestnet Asset Management Inc. (0.29%), Patten & Patten Inc. TN (0.29%) and Ferguson Wellman Capital Management Inc. (0.12%).

Which institutional investors are selling iShares US Pharmaceuticals ETF stock?

IHE stock was sold by a variety of institutional investors in the last quarter, including Ferguson Wellman Capital Management Inc., Murphy Capital Management Inc. and Patten & Patten Inc. TN.

Which institutional investors are buying iShares US Pharmaceuticals ETF stock?

IHE stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc..

How do I buy shares of iShares US Pharmaceuticals ETF?

Shares of IHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is iShares US Pharmaceuticals ETF's stock price today?

One share of IHE stock can currently be purchased for approximately $140.57.

How big of a company is iShares US Pharmaceuticals ETF?

iShares US Pharmaceuticals ETF has a market capitalization of $323.31 million. View Additional Information About iShares US Pharmaceuticals ETF.

What is iShares US Pharmaceuticals ETF's official website?

The official website for iShares US Pharmaceuticals ETF is http://www.iShares.com/.


MarketBeat Community Rating for iShares US Pharmaceuticals ETF (NYSEARCA IHE)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  49
MarketBeat's community ratings are surveys of what our community members think about iShares US Pharmaceuticals ETF and other stocks. Vote "Outperform" if you believe IHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Featured Article: Outstanding Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel